RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Determinanti genetici e molecolari del ruolo della COX-2 nell'aterotrombosi.
• 2 - Meccanismi cellulari e molecolari di morte e protezione neuronale
• 3 - EICOSANOIDI E MONOSSIDO DI AZOTO NEL DANNO ISCHEMICO CEREBRALE E NELLA RISOLUZIONE DELLA RISPOSTA INFIAMMATORIA AD ESSO ASSOCIATA
• 4 - Basi molecolari della citotossicità indotta dai diversi stati di aggregazione di beta amiloide: studio multidisciplinare in vitro, su colture cellulari e su modello animale.
• 5 - RUOLO DEI MECCANISMI DI SEGNALE CELLULARE E DELLE SPECIE REATTIVE DELL'OSSIGENO E DELL'AZOTO NELL'INVECCHIAMENTO CELLULARE E NELLA CRESCITA NEOPLASTICA.
• 6 - L'apoptosi nei processi immunitari ed infiammatori: caratterizzazione di meccanismi molecolari e cellulari finalizzata a interventi terapeutici innovativi.
• 7 - Modulazione dei meccanismi di apoptosi in corso di risposta immunitaria/infiammatoria: studio delle interazioni tra citochine della famiglia del TNF per la caratterizzazione di meccanismi molecolari e cellulari funzionali alla identificazione di nuovi target per la terapia di malattie croniche degenerative.
• 8 - RUOLO DEI RECETTORI ATTIVATI DALLE PROTEASI (PAR)- 1 e 2 NELL'INFIAMMAZIONE ED IN PROCESSI FIBROTICI AD ESSA CORRELATI.
• 9 - Meccanismi di danno e protezione nel miocardio ischemico
• 10 - RUOLO DEL GENE LOX-1 E DELLE SUE ISOFORME NEL MECCANISMO DI PROTEZIONE DA RISCHIO DI ATEROSCLEROSI ED INFARTO

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze biologiche
  • FARMACOLOGIA
• Area scientifico disciplinare: Scienze mediche

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY (installation for fermenting manure A01C3/02; preservation of living parts of humans or animals A01N1/02; physical or chemical apparatus in general B01; malting or mashing apparatus C12C1/00; brewing apparatus C12C13/00; fermentation apparatus for wine C12G; apparatus for preparing vinegar C12J1/10)
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)

Classificazione geografica

• Regione: Sicilia

Bibliografia

1 Koo EH, Lansbury PT Jr, Kelly JW, A-beta diseases: abnormal protein aggregation in neurodegeneration, Proc Natl Acad Sci U S A,96:9989-90,1999
2 Stepanichev MY, Zdobnova IM, Zarubenko II, Moiseeva YV, Lazareva NA, Onufriev MV, Gulyaeva NV, A-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus, Physiol Behav,80:647-55,2004
3 Scarpini E, Scheltens P, Feldman H, Treatment of Alzheimer's disease: current status and new perspectives, Lancet Neurol,2:539-47,2003
4 Lee VM, Giasson BI, Trojanowski JQ, More than just to peas in a pod: common amyloidogenic properties of tau and beta-synuclein in neurodegenerative diseases, Trends Neurosci,27:129-34,2004
5 Small DH, Mok SS, Bornstein JC, Alzheimer’s disease and A-beta toxicity: from top to bottom, Nat Rev Neurosci,2:539-47,2003
6 Esteban JA, Living with the enemy: a physiological role for A-beta, Trends Neurosci,27:1-3,2004
7 Parihar MS, Hemnani T, Alzheimer’s disease pathogenesis and therapeutic interventions, J Clin Neurosci,in press (online)
8 Drouet B, Pincon-Raymond M, Chambaz J, Pillot T, Molecular basis of Alzheimer's disease, Cell Mol Life Sci,57:705–15,2000
9 Mattson MP, Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease, J Neurovirol,8:539-50,2002
10 McGeer PL, McGeer EG, Local neuroinflammation and the progression of Alzheimer's disease, J Neurovirol,8:529-38,2002
11 Wilms H, Sievers J, Dengler R, Bufler J, Deuschl G, Lucius R, Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in ALS: further evidence for microglial activation in neurodegeneration, J Neuroimmunol,144:139-42,2003
12 Dietrich PY, Walker PR, Saas P, Death receptors on reactive astrocytes: a key role in the fine tuning of brain inflammation?, Neurology,60:548-54,2003
13 Chan A, Seguin R, Magnus T, Papadimitriou C, Toyka KV, Antel JP, Gold R, Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta, Glia,43:231-42,2003
14 Combs CK, Karlo JC, Kao SC, Landreth GE, A-beta stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis, J Neurosci,21:1179-88,2001
15 Malchiodi-Albedi F, Domenici MR, Paradisi S, Bernardo A, Ajmone-Cat MA, Minghetti L, Astrocytes contribute to neuronal impairment in A-beta toxicity increasing apoptosis in rat hippocampal neurons, Glia,34:68-72,2001
16 Li Y, Liu L, Barger SW, Griffin WS, IL-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway, J Neurosci,23:1605-11,2003
17 Hu J, Ferreira A, Van Eldik LJ, S100-beta induces neuronal cell death through nitric oxide release from astrocytes, J Neurochem,69:2294-2301,1997
18 Solenski NJ, Kostecki VK, Dovey S, Periasamy A, Nitric-oxide-induced depolarization of neuronal mitochondria: implications for neuronal cell death, Mol Cell Neurosci,24:1151-69,2003
19 Lynch AM, Lynch MA, The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation, Eur J Neurosci,15:1779-88,2002
20 Li R, Yang L, Lindholm K, Konishi Y, Yue X, Hampel H, Zhang D, Shen Y, TNF death receptor signaling cascade is required for A-beta-induced neuron death, J Neurosci,24:1760-71,2004
21 Verbeek MM, De Jong D, Kremer HP, Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases, Ann Clin Biochem,40:25-40,2003
22 Mechoulam R, Spatz M, Shohami E, Endocannabinoids and neuroprotection, Sci STKE, RE5,2002
23 Mechoulam R, Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression, Prostaglandins Leukot Essent Fatty Acids,66:93-9,2002
24 Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C, Neuroprotective properties of cannabinoids against oxidative stress: role of CB1 receptor, J Neurochem,80:448-56,2002
25 Milton NG, Anandamide and noladin ether prevent neurotoxicity of the human A-beta, Neurosci Lett,332:127-30,2002
26 Pertwee RG, Pharmacology of cannabinoid CB1 and CB2 receptors, Pharmacol Ther,74:129-80,1997
27 Cabral GA, Harmon KN, Carlisle SJ, Cannabinoid-mediated inhibition of inducible nitric oxide production by rat microglial cells: evidence for CB1 receptor participation, Adv Exp Med Biol,493:207-14,2001
28 Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Leon A, Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with LPS, Glia,41:161-8,2003
29 Guzman M, Sanchez C, Galve-Roperh I, Control of the cell survival/death decision by cannabinoids, J Mol Med,78:613-25,2001
30 Mechoulam R, Panikashvili D, Shohami E, Cannabinoids and brain injury: therapeutic implications, Trends Mol Med,8:58-61,2002
31 van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisogno T, Bar PR, Veldink GA, Vliegenthart JF, Di Marzo V, Nicolay K, Exogenous anandamide protects rat brain against acute neuronal injury in vivo, J Neurosci,21:8765–8771,2001
32 Parmentier-Batteur S, Jin K, Mao XO, Xie L, Greenberg DA, Increased severity of stroke in CB1 receptor knock-out mice, J Neurosci,22:9771-5,2002
33 Sinor AD, Irvin SM, Greenberg DA, Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats, Neurosci Lett,278:157–60,2000
34 Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, Romero J, CB2 receptors and FAAH are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains, J Neurosci,23:11136-41,2003
35 Maccarrone M, Bari M, Battista N, Finazzi-Agro A, Endocannabinoid degradation, endotoxic shock and inflammation, Curr Drug Targets Inflamm Allergy,1:53-63,2002
36 Carlisle SJ, Marciano-Cabral F, Staab A, Ludwick C, Cabral GA, Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation, Int Immunopharmacol,2:69-82,2002
37 Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N, Nonpsychotropic cannabinoid receptors regulate microglial cell migration, J Neurosci,23:1398-405,2003
38 Grundy RI, Rabuffetti M, Beltramo M, Cannabinoids and neuroprotection, Mol Neurobiol,24:29-51,2001
39 Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, Romero J, CB2 receptors and FAAH are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains, J Neurosci,23:11136-41,2003
40 Waksman Y, Olson JM, Carlisle SJ, Cabral GA, The central CB1 receptor mediates inhibition of nitric oxide production by rat microglial cells, J Pharmacol Exp Ther,288:1357-66,1999
41 Frautschy SA, Baird A, Cole GM, Effects of injected Alzheimer A-beta cores in rat brain, Proc Natl Acad Sci USA,88:8362-66,1991
42 Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E, An endogenous cannabinoid (2-AG) is neuroprotective after brain injury, Nature,413:527–31,2001
43 Klegeris A, Bissonnette CJ, McGeer PL, Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor, Br J Pharmacol,139:775-86,2003
44 Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, Izzo AA, Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on A-beta-induced toxicity in PC12 cells, J Neurochem,89:134-141,2004
45 Mechoulam R, Parker LA, Gallily R, Cannabidiol: an overview of some pharmacological aspects, J Clin Pharmacol,42(Suppl):11S-19S,2002

Parole Chiave

MORBO DI ALZHEIMER; BETA AMILOIDE; ENDOCANNABINOIDI; IPPOCAMPO; MORTE NEURONALE; GLIA; NEUROTRASMETTITORI; MEMORIA; RATTO